The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Stanoevich I.V.

Kafedra akusherstva i ginekologii #1 lechebnogo fakul'teta

Dzeranova L.K.

ndokrinologicheskiĭ nauchnyĭ tsentr Minzdrava RF, Moskva

Kudrina E.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Vorotnikova S.Iu.

ndokrinologicheskiĭ nauchnyĭ tsentr Minzdrava RF, Moskva

Lutsenko A.S.

National Medical Research Center of Endocrinology, Ministry of Health of Russia, Moscow, Russia

Grezina E.V.

National Medical Research Center of Endocrinology, Ministry of Health of Russia, Moscow, Russia

Mamkhegova B.S.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Clinical features of adenomyosis in acromegaly

Authors:

Stanoevich I.V., Dzeranova L.K., Kudrina E.A., Vorotnikova S.Iu., Lutsenko A.S., Grezina E.V., Mamkhegova B.S.

More about the authors

Read: 1342 times


To cite this article:

Stanoevich IV, Dzeranova LK, Kudrina EA, Vorotnikova SIu, Lutsenko AS, Grezina EV, Mamkhegova BS. Clinical features of adenomyosis in acromegaly. Russian Bulletin of Obstetrician-Gynecologist. 2018;18(2):71‑76. (In Russ.)
https://doi.org/10.17116/rosakush201818271-76

References:

  1. Corson SL. Endometriosis: the enigmatic disease. Essential Medical Information Systems. Canada. 1992;156-187.
  2. Becker C, Gattrell W, Gude K, Singh S. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertility and Sterility. 2017;108:1:125-136. https://doi.org/10.1016/j.fertnstert.2017.05.004
  3. Adamyan LV, Andreeva EN, Apolikhina IA. Endometriosis: diagnostics, treatment and rehabilitation. 2013;87. (In Russ.)
  4. Ishhenko AI, Kudrina EA. Endometriosis: modern aspects. Moscow: MIA. 2008;3-11. (In Russ.)
  5. Stanoevich IV. Benign hyperplastic diseases of uterus: pathogenesis, diagnostics, treatment and prophylaxis: Avtoref. dis... d-ra med. nauk. Moscow. 2013;48. (In Russ.)
  6. Shklyar AA, Adamyan LV, Kogan EA. Clinical and morphological features of diffuse and nodal form of adenomyosis. Problemy reproduktsii. 2015;21:1:74-79. (In Russ.) https://doi.org/10.17116/repro20152174-79
  7. Dedov II. Clinical neuroendocrinology. Moscow: UP Print. 2011;343. (In Russ.)
  8. Chang AY, Auchus RJ. Endocrine disturbances affecting reproduction. In Yen and Jaffe’s. 7th ed. Reproductive Endocrinology: Elsevier Inc. 2013;551-564. https://doi.org/10.1016/B978-1-4557-2758-2.00025-1
  9. Vorotnikova SYu, Pigarova EA, Dzeranova LK. Metabolic effects of growth hormone. Ozhirenie i metabolism. 2011;4:55-59. (In Russ.)
  10. Pronin AV, Kiryushchenkov AP, Mel’nichenko GA. Reproductive system of women with acromegaly. Vestnik reproduktivnogo zdorov’ya. 2011;1:20-23. (In Russ.)
  11. Zaidieva YaZ, Rifatova AV. Acromegaly in women: A gynecologist’s opinion. Rossiiskii vestnik akushera-ginekologa. 2014;14:3:38-42. (In Russ)
  12. Goenka L, George M, Sen M. A peek into the drug development scenario of endometriosis — a systematic review. Biomed Pharmacother. 2017;90:575-585. https://doi.org/10.1016/j.biopha.2017.03.092
  13. Li J, Peng X, Zeng X, Liu B, Hao Q, Yu X, Zhu L, Hu Q. Estrogen secreted by mesenchymal stem cells necessarily determines their feasibility of therapeutical application. Sci Rep. 2015;19:5:15286. https://doi.org/10.1038/srep15286
  14. Pontis A, D’Alterio MN, Pirarba S, de Angelis C, Tinelli R, Angioni S. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol. 2016;32:9:696-700. https://doi.org/10.1080/09513590.2016.1197200
  15. Gershtein ES, Kushlinskii NE. Growth factors, their receptors and downstream signaling proteins: from experiment to clinic. In monografy: molecular cancerogenesis. ABV-press. 2016;374-393. (In Russ.)
  16. Merritt MA, Strickler HD, Einstein MH, Yang HP, Sherman ME, Wentzensen N, Brouwer-Visser J, Cossio MJ, Whitney KD, Yu H, Gunter MJ, Huang GS. Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes Control. 2016;27:6:737-748. https://doi.org/10.1007/s10552-016-0751-4
  17. Evans A, Jamieson SM, Liu DX, Wilson WR, Perry JK. Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model. Cancer Lett. 2016;28:379:1:117-123. https://doi.org/10.1016/j.canlet.2016.05.031
  18. Zhang H, Gu M, Wang C. The expression of the receptors of estrogen, progesterone, epidermal growth factor and growth hormone in uterine adenomyosis and a comparative study after treatment with androgen. Zhonghua Fu Chan Ke Za Zhi. 1999;34:4:210-213.
  19. Slater M, Cooper M, Murphy CR. Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma. Acta Histochem. 2006;108:1:13-18. https://doi.org/10.1016/j.acthis.2006.01.004
  20. Singh S, Chakravarty AA, Manchanda S, Mallik R, Chopra S, Ajmani A, Kulshreshtha B. Effect of octreotide on endometriosis in acromegaly: case report with review of literature. Indian J Endocrinol Metab. 2014;18:2:241-244. https://doi.org/10.4103/2230-8210.129122
  21. Nagasawa H, Noguchi Y, Mori T, Niki K, Namiki H. Suppression of normal and preneoplastic mammary growth and uterine adenomyosis with reduced growth hormone level in SHN mice given monosodium glutamate neonatally. Eur J Cancer Clin Oncol. 1985;21:12:1547-1551.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.